The first category included biopharmaceuticals, complex generic drugs, patented drugs or drugs nearing patent expiry, cell-based or gene therapy drugs, orphan drugs, special empty capsules like HPMC, pullulan, enteric etc., complex excipients, and phytopharmaceuticals.from Industry-Economic Times
Read The Rest:economictimes...
